To (1) compare clinical characteristics of psoriatic arthritis (PsA) patients with PsA mutilans (PAM) and without PAM; (2) determine the rate of PAM radiographic progression.
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INTRODUCTION
Psoriatic arthritis (PsA) is a chronic inflammatory disease of the musculoskeletal system, that can also affect extraarticular structures. Five patterns of PsA were described in 1973 by Moll et al.: asymmetric oligoarthritis, symmetric polyarthritis, distal interphalangeal joint-predominant arthritis, spondylitis, and arthritis mutilans (1) . The most extreme, albeit rarest form of PsA is psoriatic arthritis mutilans (PAM).
Arthritis mutilans is a condition characterised by severe destruction of the joint and adjacent bone through erosion and subsequent osteolysis. As a result of soft-tissue laxity and loss of bone stock, fingers and toes can shorten, giving rise to thick transverse folds of skin, and digits that can be elongated with traction. Two such cases were first described in 1913 by Marie et al. , who compared the phenomena with the telescopic action of an opera glass (la main en lorgnette) (2) . Earlier in 1888, Bourdillon first reported a resorptive arthropathy associated with psoriasis (3) . Arthritis mutilans can occur in association with several diseases, including psoriatic arthritis (PAM) (1), rheumatoid arthritis (4, 5), chronic reactive arthritis, juvenile chronic arthritis and mixed connective tissue disease (6) . Its pathogenesis is unknown.
Research of PAM has been impeded by the rarity of the subphenotype, and the lack of an agreed clinical or radiographic definition. Estimates of the prevalence of PAM in PsA cohorts range from 0.6 to 21% (1, (7) (8) (9) (10) (11) , but are likely to be closer to 5% as was originally described by Moll and Wright (1) and subsequently by others (9) (10) (11) . A recent population-based study estimated the prevalence of PAM in the adult Nordic population to be 3.69 per million inhabitants, and with similar sex distribution (12) . Studies to date have been cross-sectional, with no longitudinal data.
Recent reports are mostly case series (13) (14) (15) , with a few studies of between 6 to 24 cases each (9, 10, (16) (17) (18) (19) , and only one large study of 59 cases (12) . The majority of studies simply note the occurrence of PAM in a general PsA cohort. To our knowledge, the natural clinical and / or radiographic history of PAM has never been described.
Our study objectives were to: (1) compare the clinical characteristics of PsA patients with PAM and without PAM (non-PAM); (2) determine the rate of PAM radiographic progression. 
MATERIALS & METHODS
Peripheral radiographic scoring methods
As no existing plain radiographic score for PsA captures the various radiographic features of PAM, components of existing radiographic tools were used. Plain radiographs of hands and feet were quantitatively scored for osteolysis, erosion (using the PsA-modified Sharp score; mSS (21, 22)), joint space narrowing (mSS), osteoproliferation (PsA Ratingen Score; PARS (23)), periostitis (mSS), tuft resorption (mSS), and osteopaenia using the PsA-modified Steinbrocker score (24) . A new domain to score osteolysis was devised to aid the detection of PAM and capture progression; with a range of 0 to 12, and based upon lysis of bone from the articular surface of the epiphysis, through the metaphysis, to the diaphysis (Figure 1 ).
Reading strategy and reliability exercise
Standard digital antero-posterior radiographs of the hands and feet were viewed and scored using the hospital's Picture Archiving and Communication System (PACS). Historical hard-film plain radiographs, preceding the advent of PACS in our institution (February 2007), were digitised to HiPAX Image Viewer for scoring. All images were read on the same viewing monitor, preserved at the original 1:1 ratio. All radiographs included a 'phantom phalanx' as a reference for normal bone mineral density.
The two readers (DJ, WT) underwent pre-study training in the precise definitions of radiographic findings of PsA (25), practice, supervision and discussion with an experienced Consultant musculoskeletal radiologist (GR). To determine inter-rater reliability, ten random pairs of hand and feet radiographs were scored by both the readers, in random order.
Identification of PAM cases
In keeping with previous publications on PAM (8, 16, 17) , plain radiographic PAM was defined as osteolysis affecting ≥50% of the visualised articular surface on both sides of the joint. A large erosion qualified as osteolysis once the epiphyseal plate was encroached. PAM was therefore only called once the osteolysis score in an individual joint was ≥4 units.
The most recent plain radiographs of hands and feet were evaluated for PAM (DJ). Group consensus (DJ, WT, NM, GR) was sought for uncertain cases. All available radiographs of PAM cases (earliest to most recent) were then randomised and scored by the two readers (DJ, WT).
Axial radiographic scoring methods
All cases had their most recent axial plain radiographs (cervical spine, lumbar spine, and sacroiliac joints, as available) scored for evidence of radiographic spondylitis and / or sacroiliitis by one reader (DJ) following education and practice with GR. In keeping with previous publications (26, 27) , radiographic axial disease was defined as: the presence of New York criteria unilateral grade ≥3, or bilateral grade ≥2 sacroiliitis on AP pelvic radiograph; and / or ≥1 marginal / paramarginal syndesmophyte(s) of the cervical, or lumbar spine.
Statistical analysis
Data were analysed using 'R' (28) . Inter-rater reliability testing was performed using intra-class correlation coefficients (ICCs).
For univariate analyses continuity-corrected Chi-squared tests were used to test for differences between categorical variables, and independent t-tests or Mann-Whitney U-tests used for normally or non-normally distributed continuous variables, respectively. Unadjusted odds ratios (OR), associated 95% confidence intervals (95% CI), and p-values using an alpha-level of 0.05 were calculated.
Multivariate analysis was performed to compare the prevalence of axial radiographic disease in PAM and non-PAM, using a logistic regression with adjustment for sex and age at most recent pelvis radiograph. Multivariate analysis was performed to compare HAQ scores in PAM and non-PAM, using a zero-inflated Poisson regression (29) with adjustment for sex and age at HAQ assessment.
Patterns and rates of deterioration of individual joints over time were examined for all patients. Initial analysis consisted of plotting the data together with locally-weighted polynomial regression smoothers (lowess) (30) . Formal modelling of the changes in scores over time was performed using generalised additive mixed models (GAMM) (31), using penalised splines to assess the complexity of the model required for each joint and allowing a random effect for each patient. For each joint, the required complexity was expressed as the effective degrees of freedom (EDF). An EDF of one signifies a linear change in scores over time, i.e. a constant rate of deterioration from date of diagnosis,
with larger values indicating that rates of deterioration over time are more complex.
Ethical considerations
Ethical approval for the study was given by the Local Regional Ethics Committee and informed written consent obtained from participants.
RESULTS
610 PsA cases fulfilling classification criteria for psoriatic arthritis (CASPAR) (32, 33) were screened for the presence or absence of plain radiographic PAM. 36/610 (5.9%) had PAM, with 35/36 having serial radiographs. 483/610 had no evidence of PAM. 91/610 either had no radiographs of hands and feet, or only one of the two sites imaged, and therefore although unlikely, PAM could not be excluded.
Inter-rater reliability of plain radiographic scoring
The inter-rater reliability of peripheral plain radiographic scoring was very high: intra-class correlation (ICC) 0.99 (95% CI 0.98 -1.00) for osteolysis; ICC 0.95 (95% CI 0.91 -0.99) for erosion; ICC 0.97 (95% CI 0.95 -0.99) for osteoproliferation; and ICC 0.90 (95% CI 0.84 -0.93) for osteopaenia.
Clinical characteristics of PAM and non-PAM cases
The proportion of females in the PAM and non-PAM cohorts were similar (52.78 vs. 47.20%, respectively; p=0.52). Table 2) .
PAM cases were more likely to have radiographic axial disease than non-PAM cases (adjusted OR 2.31; 95% CI 1.07 -4.97; adjusted p=0.03) ( Table 2) . PAM cases were more likely to have radiographic sacroiliitis than non-PAM cases (adjusted OR 2.99; 95% CI 1.33 -6.73; adjusted p=0.01). When sacroiliitis was present in PAM cases it tended to be bilateral (9/11; 81.82%) and of grade ≥3 (11/11; 100%) ( Table 2) .
Radiographic characteristics of PAM cases
The median number of films (pairs of hands and feet) scored per patient was 5 (IQR 3 -7) ( Table 3) . At the most recent film, the most frequently affected joint was the big toe interphalangeal joint (IPJ1) (8.81%), followed in equal frequency (6.92%) by the thumb metacarpophalangeal joint (MCPJ1), index finger distal interphalangeal joint (DIPJ2), little finger proximal interphalangeal joint (PIPJ5), and feet metatarsophalangeal joints 2 to 5 (MTPJ2-5) (Figure 2) .
Of note, 12/35 (34.29%) PAM cases had concurrent evidence of joint osteolysis and ankylosis within the same hand or foot ( Table 3) . 2/35 PAM cases had proceeded to having surgery on the joint affected by PAM; due to impaired hand function in one case, and pain in the other case ( Table 3) .
Radiographic progression of PAM
35/36 PAM cases had serial radiographs available for scoring. For hands and feet combined, at the most recent film the median osteolysis score was 2.00 (IQR 0.00 -15.00) units, erosion score 9.00 (IQR 0.00 -26.00) units, joint space narrowing score 14.00 (IQR 0.00 -31.00) units, osteoproliferation score 3.00 (IQR 0.00 -6.00) units, and osteopaenia score 0.00 (IQR 0.00 -2.00) units.
A significant change in osteolysis score over time was observed for all joints (p<0.008). After allowing for patient differences in a random effects model, there was a strong indication that different joints had different patterns of deterioration over time (p<0.001). The best fit regression curve, 95% confidence interval bands, and the effective degrees of freedom (EDF) for each curve are shown for the hands and feet joints separately. In the feet, there is an initial high rate of osteolysis, followed by a tapering rate, and eventually little further progression of osteolysis (EDF=3.1). However, in the hands the curve is more complex (EDF=4.3) with an initially high increase in osteolysis, followed by a tapering in the rate. For some patients there was indication of a second surge of osteolysis in some joints later during disease course, adjusted for the time since diagnosis.
PAM cases with a history of psoriatic nail dystrophy (30/36) had significantly higher overall osteolysis scores in topographically related joints (DIPJ / PIPJ / IPJ) of the hands, than those without nail dystrophy (6/36) (mean scores;
3.0 with nail dystrophy, 1.3 without nail dystrophy; p= 0.03).
DISCUSSION
We have taken advantage of a well-characterised cohort of PsA patients followed longitudinally in a single centre to compare the clinical characteristics of PAM and non-PAM cases, and investigate the natural radiographic history of PAM. To our knowledge, this is the largest sample of PAM cases with a detailed description of plain radiographic characteristics, and the first study to report on radiographic progression.
A previous study by our group showed that nail dystrophy is more common in PsA patients with DIP joint disease, and is significantly associated with adjacent DIP joint disease (33) . Here we demonstrate that psoriatic nail dystrophy is a clinical biomarker of both PAM occurence, and of having more severe osteolysis in topographically adjacent joints (hand DIP, PIP and IP joints). This has not previously been reported. Furthermore, PAM was most commonly seen in the weight-bearing joints of the feet (MTPJ 2-5, IPJ1) and hand joints involved in power / precision grip (DIPJ2, MCPJ1). Little is known about the pathogenesis or trigger for PAM. The concept of altered biomechanical loads or stress on the synovial-entheseal complex being involved in the pathogenesis of SpA, as proposed by McGonagle et al. (34, 35) , is supported by our current findings in PAM.
There has been debate as to whether involvement of a single joint is sufficient for a case to be defined as PAM (36) .
Our data indicates that 7/35 (20%) have monoarticular PAM, even after several years of follow-up. Review of these seven cases in our outpatient clinic demonstrated clinical evidence of PAM, with shortened telescopic digits. We therefore propose that PAM can be monoarticular, although it is more frequently polyarticular and the notion is supported by data from other studies (1, 12, 13, 18) .
Several of our results corroborate those of the Classification of Psoriatic Arthritis (CASPAR) dataset (18) , which showed that PAM cases are usually polyarticular, of long disease duration, and are more prone to spinal involvement compared to their non-PAM counterparts. In our cohort there was a higher prevalence of sacroiliitis, that tended to be more severe than in non-PAM cases, and some increase in other features of spondylitis. However, we did not replicate the CASPAR findings of more frequent ACPA-positivity (albeit of low titre) in PAM compared with non-PAM cases.
Joint surgery rates in our cohort of PAM cases were far lower than the 48% reported by Helliwell et al. (18) .
A further intriguing issue is the nature of the relationship between osteolysis and ankylosis. In our dataset, 12/35 (34.29%) cases had concurrent osteolysis and ankylosis in the same hand or foot. Occasionally, osteolysis progressed to joint ankylosis in the same joint, but more commonly we saw joint space narrowing progressing to ankylosis, suggesting that there are two separate pathogenic processes although both may occur in the same patient.
None of our PAM cases had improvement of osteolysis, erosion or osteoproliferation scores. Joint space narrowing, osteopaenia and periostitis scores fluctuated, with both regression and progression. There are emerging reports in the literature of improvement in erosion (37, 38) and joint-space narrowing (38) scores following anti-TNF use, implying filling-in or 'healing' of previous structural damage. However, a paper reporting the follow-up of three PAM cases treated with etanercept, demonstrated no improvement in deformities resulting from several years of progressive disease (14) . Furthermore, our data suggests that neither synthetic DMARDs nor anti-TNF prevent the onset of radiographic PAM. Our findings need to be interpreted with caution in a retrospective study where the radiographs were not taken at fixed time intervals, hence sensitivity to detect PAM onset is reduced, and the doses of some agents such as methotrexate were lower than those used nowadays.
The sequence of pathological events leading to the frank osteolysis of PAM is of much interest. Magnetic resonance imaging has demonstrated higher bone proliferation and oedema scores in PAM compared with non-PAM cases, and has therefore been proposed as a potential radiological biomarker of progressing to PAM (16) . In our study we did not see osteopaenia or periostitis preceding the onset of erosions or osteolysis. Nor did we overtly see progressive erosions prior to the onset of osteolysis. However, we acknowledge that the varied time interval between radiographs may have reduced our sensitivity to track such changes. In our general observations we noted progressive joint space narrowing prior to the onset of osteolysis.
We acknowledge that our study has limitations. Whilst it appears that 36/519 (6.94%) of our cohort suffer PAM, we are aware that 91/610 PsA cases had insufficient or no radiographs to assess the presence or absence of PAM. The lack of radiographs may imply minimal disease activity at these sites, or may be due to non-clinical factors. Assuming that all 91 were non-PAM cases, the prevalence of PAM in our cohort falls to 36/610 (5.90%). However, both estimates are within the range of prevalence described by other authors (1, (7) (8) (9) (10) (11) . Secondly, since the interval between films was determined by clinical need, rather than predefined intervals, we are unable to determine the incidence of PAM onset.
Since PAM was evident in the earliest available radiograph in 13/35 (37.14%) of cases, the initial rate of radiographic progression could not be determined in this subgroup of patients.
To conclude, PAM is a rare but severely destructive subphenotype of PsA. Further research is need to investigate the pathogenesis of PAM, the chronology of pathological events, genetic and / or serum-soluble biomarkers of PAM, and whether anti-TNF or anti-resorptive agents may offer therapeutic efficacy.
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